We have sent a letter to Senate Health, Education, Labor and Pensions (HELP) Committee leadership that highlights the implications of the Verifying Accurate Leading-edge IVCT Development (VALID) Act. Because the bill would modify the regulatory framework for laboratory developed tests, the VALID Act could have serious unintended consequences for children’s health and children’s hospitals. We are asking the committee to address those concerns before advancing the Senate FDA user fee package legislation that includes the VALID Act.
VALID Act Letter
We sent a letter to Senate HELP Committee leadership to highlight the implications of the VALID Act.
Related Content
Protecting 340B Allows Hospitals to Invest Millions in Children's Health
Protect and Preserve 340B for Children’s Hospitals
A Win for Kids — And Why 340B Still Needs Defending
Protecting 340B Allows Hospitals to Invest Millions in Children's Health
A recent assessment showed children’s hospitals participating in the federal drug pricing discount program save hundreds of millions annually — and invest even more into their communities.
March 03, 2026
Protect and Preserve 340B for Children’s Hospitals
The 340B program ensures access to care for children.
Feb. 12, 2026
A Win for Kids — And Why 340B Still Needs Defending
The federal program allows hospitals that treat large numbers of low-income patients to purchase outpatient drugs at lower prices.
Jan. 27, 2026
